Skip to main content
. 2015 Jun 9;6(2):143–152. doi: 10.1007/s13300-015-0115-1

Fig. 1.

Fig. 1

Study design. CGM continuous glucose monitoring, Gla-300 insulin glargine 300 U mL−1, Gla-100 insulin glargine 100 U mL−1